MDxHealth is trading at $0.21, up 5.56%, with no new company-specific announcement identified to explain the October 21 move.
- Healthcare is up 2.12% in the supplied market context, which may support the rebound, but no direct link to MDxHealthβs move is established.
- The October 15 revenue update is earlier context, not a confirmed cause; it cited unexpected sales-force turnover and preliminary revenue of about $22.7 million.
- It also suspended full-year 2026 guidance.